nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Altered germinal center responses in mice vaccinated with highly pathogenic avian influenza A(H5N1) virus
|
Seiler, Patrick |
|
|
60 |
C |
p. |
artikel |
2 |
A phase I, randomized, placebo-controlled, double-blind, ascending-dose and single-center study to evaluate immunogenicity and safety of a live attenuated tetravalent dengue vaccine (KD-382) in Flavivirus antibody-naïve healthy adults
|
Abe, Motoharu |
|
|
60 |
C |
p. |
artikel |
3 |
Assessment of homologous and heterologous PCV2 vaccine efficacy in a PCV2d/PRRSV co-challenge model
|
Kroeger, Molly |
|
|
60 |
C |
p. |
artikel |
4 |
Averted mortality by COVID-19 vaccination in Belgium between 2021 and 2023
|
Stouten, Veerle |
|
|
60 |
C |
p. |
artikel |
5 |
Cardiac monitoring safety assessment framework for early phase group a streptococcal vaccine trials
|
Marangou, James |
|
|
60 |
C |
p. |
artikel |
6 |
Co-administration of vaccines in pregnancy: unique challenges and knowledge gaps
|
Abu-Raya, Bahaa |
|
|
60 |
C |
p. |
artikel |
7 |
COVID-19 vaccination and utility of booster dose: A community-based cross-sectional study
|
Yadav, Geeta |
|
|
60 |
C |
p. |
artikel |
8 |
Development and characterization of MRC-5 and Vero cell-adapted enterovirus D68 strains for vaccine production
|
Senpuku, Kota |
|
|
60 |
C |
p. |
artikel |
9 |
Editorial Board
|
|
|
|
60 |
C |
p. |
artikel |
10 |
Immune persistence after 5 years of vaccination by Vi-DT vaccine among children below 2 years: Result from long-term observational study
|
Pial, Rejwana Haque |
|
|
60 |
C |
p. |
artikel |
11 |
Immunogenicity evaluation of a recombinant pseudorabies virus co-expressing PCV2 and PCV3 capsid proteins in mice and piglets
|
Li, Hui |
|
|
60 |
C |
p. |
artikel |
12 |
Limited durability of protection conferred by XBB.1.5 vaccines against omicron-associated severe outcomes among community-dwelling adults, Ontario, Canada
|
Lee, Nelson |
|
|
60 |
C |
p. |
artikel |
13 |
Malaria vaccine acceptance and associated factors in cameroon: A nationwide cross-sectional survey
|
Njoh, Andreas Ateke |
|
|
60 |
C |
p. |
artikel |
14 |
National trends and disparities in herpes zoster vaccination coverage among U.S. older adults with cancer, 2008–2023
|
Hung, Chun-Tse |
|
|
60 |
C |
p. |
artikel |
15 |
Nationwide rollout of HPV vaccination in Nepal: Early key insights
|
Devkota, Bikash |
|
|
60 |
C |
p. |
artikel |
16 |
PcrV in an intranasal adjuvanted tobacco mosaic virus conjugate vaccine mediates protection from Pseudomonas aeruginosa via an early Th1/Th17 skewed localized and systemic immune response.
|
Katseff, Adiya S. |
|
|
60 |
C |
p. |
artikel |
17 |
Prediction of subnational-level vaccination coverage estimates using routine surveillance data and survey data
|
Bhatia, Deepit |
|
|
60 |
C |
p. |
artikel |
18 |
Prioritizing interventions to address healthcare worker barriers to reporting adverse events following immunization in Ghana
|
Laryea, Sharon |
|
|
60 |
C |
p. |
artikel |
19 |
Risk of Guillain-Barré syndrome after COVID-19 vaccination or SARS-CoV-2 infection: A multinational self-controlled case series study
|
Nasreen, Sharifa |
|
|
60 |
C |
p. |
artikel |